Rhythm Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/07/2025 | 6.95 M | $389.10 M | 0.89% | 11.35% |
| PRIMECAP MANAGEMENT CO/CA/ | 02/10/2025 | 6.57 M | $367.86 M | -8.95% | 10.73% |
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 6.08 M | $340.61 M | 0.00% | 9.94% |
| BAKER BROS. ADVISORS LP | 02/14/2025 | 6.08 M | $340.60 M | -4.91% | 9.94% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 3.68 M | $206.03 M | 3.38% | 6.01% |
| VANGUARD GROUP INC | 02/11/2025 | 3.44 M | $192.72 M | -0.15% | 5.62% |
| NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 2.91 M | $162.90 M | 0.00% | 4.75% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 02/18/2025 | 1.87 M | $104.67 M | -22.64% | 3.05% |
| STATE STREET CORP | 02/14/2025 | 1.84 M | $103.05 M | -7.64% | 3.01% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.81 M | $101.45 M | -53.29% | 2.96% |
| FEDERATED HERMES, INC. | 02/13/2025 | 1.55 M | $86.75 M | -6.87% | 2.53% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 1.50 M | $83.97 M | 0.00% | 2.45% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.29 M | $72.27 M | -0.66% | 2.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.26 M | $70.32 M | -0.03% | 2.05% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 1.22 M | $68.31 M | 103.90% | 1.99% |
| ALKEON CAPITAL MANAGEMENT LLC | 02/14/2025 | 1.17 M | $65.37 M | 0.00% | 1.91% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 1.16 M | $65.09 M | -5.32% | 1.90% |
| CHECKPOINT CAPITAL L.P. | 02/14/2025 | 727.98 K | $40.75 M | 9.74% | 1.19% |
| MARSHALL WACE, LLP | 02/13/2025 | 692.80 K | $38.78 M | 70.38% | 1.13% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 685.15 K | $38.36 M | 24.45% | 1.12% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/14/2025 | 643.69 K | $36.03 M | 4.73% | 1.05% |
| LOOMIS SAYLES & CO L P | 02/12/2025 | 618.49 K | $34.62 M | -2.85% | 1.01% |
| MORGAN STANLEY | 02/14/2025 | 560.09 K | $31.35 M | 20.55% | 0.91% |
| NORTHERN TRUST CORP | 02/14/2025 | 545.31 K | $30.53 M | 9.40% | 0.89% |
| OPALEYE MANAGEMENT INC. | 02/14/2025 | 500.00 K | $27.99 M | 0.00% | 0.82% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 440.25 K | $24.65 M | 1.47% | 0.72% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 400.00 K | $22.39 M | -8.24% | 0.65% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 400.00 K | $22.39 M | 0.00% | 0.65% |
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 397.43 K | $22.25 M | 43.64% | 0.65% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 380.54 K | $21.30 M | 7.70% | 0.62% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 375.35 K | $21.01 M | 13.97% | 0.61% |
| CANDRIAM S.C.A. | 02/07/2025 | 332.39 K | $18.61 M | -15.93% | 0.54% |
| INVESCO LTD. | 02/13/2025 | 302.85 K | $16.95 M | 14.53% | 0.49% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 02/14/2025 | 273.90 K | $15.33 M | 7.17% | 0.45% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 268.21 K | $15.01 M | 3.39% | 0.44% |
| JPMORGAN CHASE & CO | 02/12/2025 | 264.59 K | $14.81 M | 224.28% | 0.43% |
| UBS GROUP AG | 02/14/2025 | 254.26 K | $14.23 M | 231.79% | 0.42% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 218.54 K | $12.23 M | -3.03% | 0.36% |
| STEMPOINT CAPITAL LP | 02/14/2025 | 208.02 K | $11.64 M | 404.06% | 0.34% |
| NORGES BANK | 02/12/2025 | 205.65 K | $11.51 M | 100.00% | 0.34% |
| SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 172.65 K | $9.66 M | 0.00% | 0.28% |
| LORD, ABBETT & CO. LLC | 02/14/2025 | 160.65 K | $8.99 M | 56.51% | 0.26% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 150.00 K | $8.40 M | 100.00% | 0.25% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 148.25 K | $8.30 M | -0.46% | 0.24% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 146.90 K | $8.22 M | -0.66% | 0.24% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 144.34 K | $8.08 M | 100.00% | 0.24% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 138.36 K | $7.75 M | 100.00% | 0.23% |
| BARCLAYS PLC | 02/13/2025 | 135.40 K | $7.58 M | 27.26% | 0.22% |
| CITADEL ADVISORS LLC | 02/14/2025 | 130.30 K | $7.29 M | 177.23% | 0.21% |
| FIRST TRUST ADVISORS LP | 02/13/2025 | 118.34 K | $6.62 M | 67.23% | 0.19% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rhythm Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 55 institutional investors and hedge funds held shares of Rhythm Pharmaceuticals, Inc.. The most heavily invested institutionals were:
EAM Global Investors LLC: 0
RAYMOND JAMES FINANCIAL INC: 0
NATIXIS: 0
Raleigh Capital Management Inc.: 0
Virtus ETF Advisers LLC: 0
TEXAS TREASURY SAFEKEEPING TRUST CO: 0
106.01% of Rhythm Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 10.52 M shares in the last 24 months. This purchase volume represents approximately $631.01 M in transactions.